Newborn screening, also called newborn screening test, is an examination carried out by health care providers to determine the health of an expecting mother and her baby. This is an important routine medical procedure to be undertaken by all healthcare professionals. Newborn screening is essentially a public health program consisting of testing in newborns for potentially treatable conditions, but not clinically proven in the newborn period, before birth. It is usually carried out before doctors make a referral to an obstetrician or gynecologist for a newborn's first examination after birth. Screening tests done during this yearly trip to the hospital include a collection of high-quality blood from the mother and the baby, evaluation of the blood for any infections, and review of the mother's medical history for any concerns about adverse reaction to medications, diabetes, blood clotting, or other serious health conditions
The growing prevalence of newborn disorders coupled with the favorable government policies are driving growth of the newborn screening market. According to the Centers for Disease Control and Prevention, birth defects affect one in every 33 babies (about 3% of all babies) born in the United States each year. Birth defects are the leading cause of infant deaths, accounting for 20% of all infant deaths. World Health Organization states that up to two-thirds of newborn deaths can be prevented if known, effective health measures are provided at birth and during the first week of life.
Asia Pacific is expected to gain significant growth over the forecast period and this is attributed to the high birth rate in the countries such as India and China. According to the UN Children’s Fund, India records 25 million births every year, or nearly one-fifth of the global annual childbirths. So high birth rate indicates a strong demand for newborn screening products in the region.
Key Developments:
- In October 2018, Trivitron Labsystems Diagnostics Oy, has expanded its portfolio on advancing newborn screening (NBS) by launching six new high-quality NBS products at ISNS 2018, Slovakia.
- In September 2020, EveryLife Foundation for Rare Diseases, Orchard Therapeutics, Sarepta Therapeutics, Inc. BioMarin Pharmaceutical Inc., and Retrophin, announced a partnership to evaluate the capacity of newborn screening in the United States to provide a timely diagnosis of all newborns
- In October 2018, CureDuchenne, the nonprofit funding scientific research, and innovation for Duchenne muscular dystrophy, announced it has entered into a three-year partnership with Baebies
Key features of the study:
- This report offers in-depth analysis of the global newborn screening market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the key players
- It profiles key players in the global newborn screening market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include, Agilent Technologies, AB SCIEX, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc., and ZenTech S.A.
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global newborn screening market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for new born screening test market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Newborn Screening Market, By Product:
Assay Kits
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Global Newborn Screening Market, By Test:
Blood Test
Cardiac Test
Hearing Test
Urine Test
Global Newborn Screening Market, By Application:
Blood Spot Disease
Critical Congenital Cardiac Disease
Maple Syrup Urine Disease
Hearing Disability
Sickle Cell Disease
Thyroid Disorder
Global Newborn Screening Market, By Region:
North America
By Country:
U.S.
Canada
By Product Type:
Assay Kits
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
By Test:
Blood Test
Cardiac Test
Hearing Test
Urine Test
By Application:
Blood Spot Disease
Critical Congenital Cardiac Disease
Maple Syrup Urine Disease
Hearing Disability
Sickle Cell Disease
Thyroid Disorder
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Product Type:
Assay Kits
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
By Test:
Blood Test
Cardiac Test
Hearing Test
Urine Test
By Application:
Blood Spot Disease
Critical Congenital Cardiac Disease
Maple Syrup Urine Disease
Hearing Disability
Sickle Cell Disease
Thyroid Disorder
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Product Type:
Assay Kits
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
By Test:
Blood Test
Cardiac Test
Hearing Test
Urine Test
By Application:
Blood Spot Disease
Critical Congenital Cardiac Disease
Maple Syrup Urine Disease
Hearing Disability
Sickle Cell Disease
Thyroid Disorder
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Product Type:
Assay Kits
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
By Test:
Blood Test
Cardiac Test
Hearing Test
Urine Test
By Application:
Blood Spot Disease
Critical Congenital Cardiac Disease
Maple Syrup Urine Disease
Hearing Disability
Sickle Cell Disease
Thyroid Disorder
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Product Type:
Assay Kits
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
By Test:
Blood Test
Cardiac Test
Hearing Test
Urine Test
By Application:
Blood Spot Disease
Critical Congenital Cardiac Disease
Maple Syrup Urine Disease
Hearing Disability
Sickle Cell Disease
Thyroid Disorder
Africa
By Country:
South Africa
Central Africa
North Africa
By Product Type:
Assay Kits
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
By Test:
Blood Test
Cardiac Test
Hearing Test
Urine Test
By Application:
Blood Spot Disease
Critical Congenital Cardiac Disease
Maple Syrup Urine Disease
Hearing Disability
Sickle Cell Disease
Thyroid Disorder
Company Profiles
Agilent Technologies*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
AB SCIEX
Bio-Rad Laboratories
Covidien PLC
GE Life Sciences
Masimo Corporation
Natus Medical Inc.
PerkinElmer Inc.
ZenTech S.A.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Product
o Market Snippet, By Test
o Market Snippet, By Application
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Technological Advancements
o Regulatory Scenario
o Reimbursement Scenario
o PEST Analysis
4. Global Newborn Screening Market, By Product, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Assay Kits
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Hearing Screening Devices
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Mass Spectrometer
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Pulse Oximetry
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
5. Global Newborn Screening Market, By Application, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Blood Spot Disease
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Critical Congenital Cardiac Disease
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Maple Syrup Urine Disease
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Hearing Disability
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Sickle Cell Disease
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Thyroid Disorder
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
6. Global Newborn Screening Market, By Test, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Blood Test
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Cardiac Test
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Hearing Test
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Urine Test
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
7. Global Newborn Screening Market, By Region, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, By Region, 2017 - 2026
o Regional Trends
o North America
o Market Size and Forecast, By Product, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Test, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Product, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Test, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Product, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Test, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Product, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Test, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
o Market Size and Forecast, By Product, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Test, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
o Northern Africa
o Central Africa
o South Africa
o Middle East
o Market Size and Forecast, By Product, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Test, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
o GCC Countries
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Agilent Technologies
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o AB SCIEX
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Bio-Rad Laboratories
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Covidien PLC
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o GE Life Sciences
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Masimo Corporation
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Natus Medical Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o PerkinElmer Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o ZenTech S.A.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 32 market data tables and 20 figures on "Newborn Screening Market" - Global forecast to 2026".
Request Discount 
Inquire Before Buy
